Gamotion
Gamotion has been studied in 1 paper since 2020: 1 trial in people. The newest paper, May 28, 2020: “The effects of GAMotion (a giant exercising board game) on physical capacity, motivation and quality of life among nursing home residents: A pilot interventional study”.
1 paper studies it4 findingsUpdated
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the experimental group displayed a greater improvement in Tinetti score (p < 0.0001)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave gamotion to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves tinetti scoregreater improvement than control group (p < 0.0001) up: Improves SPPB scoregreater improvement than control group (p < 0.0001) up: Improves EQ-5D mobility, self-care and usual activitiesgreater improvement than control group (p < 0.0001) | Trialone month | 11 peopleOlder adults; age-adjusted time*group ANOVA | Experimental gerontology, May 28, 2020 |
What did studies of gamotion find?
4Studies of gamotion measured 4 outcomes, among them intrinsic motivation, EQ-5D mobility, self-care and usual activities and SPPB score.
Intrinsic motivation
upin humans1
1 study
Intrinsic motivation
upin humans1
Gamotion increases intrinsic motivation in humans (compared with control group; age-adjusted time*group ANOVA) (greater improvement than control group (p = 0.02)).
“and intrinsic motivation (p = 0.02) compared to the control group”
Human trialcompared with control group; age-adjusted time*group ANOVAone monthn = 11
Experimental gerontology
EQ-5D mobility, self-care and usual activities
upin humans1
1 study
EQ-5D mobility, self-care and usual activities
upin humans1
Gamotion improves EQ-5D mobility, self-care and usual activities in humans (compared with control group; age-adjusted time*group ANOVA) (greater improvement than control group (p < 0.0001)).
“3 domains of the EQ-5D (i.e. mobility, self-care, usual activities: p < 0.0001)”
Human trialcompared with control group; age-adjusted time*group ANOVAone monthn = 11
Experimental gerontology
SPPB score
upin humans1
1 study
SPPB score
upin humans1
Gamotion improves SPPB score in humans (compared with control group; age-adjusted time*group ANOVA) (greater improvement than control group (p < 0.0001)).
“greater improvement in Tinetti score (p < 0.0001), TUG (p = 0.02), SPPB (p < 0.0001)”
Human trialcompared with control group; age-adjusted time*group ANOVAone monthn = 11
Experimental gerontology
Tinetti score
upin humans1
1 study
Tinetti score
upin humans1
Gamotion improves tinetti score in humans (compared with control group; age-adjusted time*group ANOVA) (greater improvement than control group (p < 0.0001)).
“the experimental group displayed a greater improvement in Tinetti score (p < 0.0001)”
Human trialcompared with control group; age-adjusted time*group ANOVAone monthn = 11
Experimental gerontology